| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.43 | 0.002 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.22 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |